Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study

Tamoxifen and aromatase inhibitors are associated with side effects which can significantly impact quality of life (QoL). We assessed QoL in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial and compared these data with reported adverse events in the main database. 2,754 Dutch postmenopau...

Descripción completa

Detalles Bibliográficos
Autores principales: van Nes, J. G. H., Fontein, D. B. Y., Hille, E. T. M., Voskuil, D. W., van Leeuwen, F. E., de Haes, J. C. J. M., Putter, H., Seynaeve, C., Nortier, J. W. R., van de Velde, C. J. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2012
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397233/
https://www.ncbi.nlm.nih.gov/pubmed/22453754
http://dx.doi.org/10.1007/s10549-012-2028-2

Ejemplares similares

Ejemplares similares